BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8644863)

  • 21. Utility of Leu M1 monoclonal antibody in the differential diagnosis of Hodgkin's disease.
    Hyder DM; Schnitzer B
    Arch Pathol Lab Med; 1986 May; 110(5):416-9. PubMed ID: 3516118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.
    Hsu SM; Xie SS; Hsu PL; Waldron JA
    Am J Pathol; 1992 Jul; 141(1):129-38. PubMed ID: 1632458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hodgkin's disease revisited: Reed-Sternberg cells as natural hybridomas.
    Sinkovics JG
    Crit Rev Immunol; 1991; 11(1):33-63. PubMed ID: 1652972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Proliferating cells in Hodgkin's disease].
    Schmid C; Isaacson PG
    Verh Dtsch Ges Pathol; 1992; 76():151-4. PubMed ID: 1283248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monokine expression in Langerhans' cell histiocytosis and sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).
    Foss HD; Herbst H; Araujo I; Hummel M; Berg E; Schmitt-Gräff A; Stein H
    J Pathol; 1996 May; 179(1):60-5. PubMed ID: 8691347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hodgkin's disease, lymphocyte-predominant type: immunoreactivity with B-cell antibodies.
    Coles FB; Cartun RW; Pastuszak WT
    Mod Pathol; 1988 Jul; 1(4):274-8. PubMed ID: 3266337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasmacytoid monocytes (so-called plasmacytoid T cells) in Hodgkin's disease.
    Facchetti F; De Wolf-Peeters C; van den Oord JJ; Desmet VJ
    J Pathol; 1989 May; 158(1):57-65. PubMed ID: 2787853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical demonstration of cathepsin B in the macrophages of benign and malignant lymphoid tissues.
    Crocker J; Burnett D; Jones EL
    J Pathol; 1984 Jan; 142(1):87-94. PubMed ID: 6366177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression of myc and ras oncogene protein in childhood lymphomas.
    Sakalidou A; Kanavaros P; Tzardi M; Kalmanti M
    Anticancer Res; 1996; 16(1):487-91. PubMed ID: 8615659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In situ expression of the IL-1-alpha and TNF-alpha genes by Reed-Sternberg cells in Hodgkin's disease.
    Xerri L; Birg F; Guigou V; Bouabdallah R; Poizot-Martin I; Hassoun J
    Int J Cancer; 1992 Mar; 50(5):689-93. PubMed ID: 1312061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fine needle aspiration cytodiagnosis of Hodgkin's disease and its subtypes. II. Subtyping by differential cell counts.
    Das DK; Gupta SK
    Acta Cytol; 1990; 34(3):337-41. PubMed ID: 2343688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ICAM-3 expression on endothelium in lymphoid malignancy.
    Doussis-Anagnostopoulou I; Kaklamanis L; Cordell J; Jones M; Turley H; Pulford K; Simmons D; Mason D; Gatter K
    Am J Pathol; 1993 Oct; 143(4):1040-3. PubMed ID: 8214000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathology and "molecular histology' of Hodgkin's disease and the border to non-Hodgkin's lymphomas.
    Hansmann ML; Küppers R
    Baillieres Clin Haematol; 1996 Sep; 9(3):459-77. PubMed ID: 8922240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokine (interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6)-possessing cells in lymph nodes of malignant lymphoma.
    Takeshita M; Sumiyoshi Y; Masuda Y; Ohshima K; Yoshida T; Kikuchi M; Müller H
    Pathol Res Pract; 1993 Feb; 189(1):18-25. PubMed ID: 8516212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leu M1 and S100 in Hodgkin's disease and non-Hodgkin's lymphomas.
    Kornstein MJ; Bonner H; Gee B; Cohen R; Brooks JJ
    Am J Clin Pathol; 1986 Apr; 85(4):433-7. PubMed ID: 3754087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of interleukin-1 in Reed-Sternberg cells and neoplastic cells from true histiocytic malignancies.
    Hsu SM; Zhao X
    Am J Pathol; 1986 Nov; 125(2):221-5. PubMed ID: 3538888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Localization of apoptosis-antagonizing bcl-2 translated product in Hodgkin's disease].
    Chen XQ; Wang WL; Huang GS
    Zhonghua Yi Xue Za Zhi; 1994 Oct; 74(10):618-20, 647. PubMed ID: 7842340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mistaken clinical and pathologic diagnoses of Hodgkin's disease: a Southwest oncology group study.
    Miller TP; Byrne GE; Jones SE
    Cancer Treat Rep; 1982 Apr; 66(4):645-51. PubMed ID: 7074635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic attributes of the malignant cell population in Hodgkin's disease indicate a monocyte/macrophage origin.
    Olsson L; Behnke O
    Cancer Surv; 1985; 4(2):421-38. PubMed ID: 3842320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymph node interdigitating cell granuloma associated with non-Hodgkin's malignant lymphoma. A case report and review of the literature.
    Szekeres G; Le Tourneau A; Audouin J; Aubert JP; Herait P; Culine S; Zittoun R; Diebold J
    Appl Pathol; 1989; 7(6):382-93. PubMed ID: 2701267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.